HOUSE DOCKET, NO. 276 FILED ON: 1/9/2019
HOUSE . . . . . . . . . . . . . . . No. 1115
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Thomas M. Stanley
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act relative to the care and treatment of patients with mitochondrial disease.
_______________
PETITION OF:
Name: | District/Address: | Date Added: |
Thomas M. Stanley | 9th Middlesex | 1/9/2019 |
James Arciero | 2nd Middlesex | 1/31/2019 |
Mark J. Cusack | 5th Norfolk | 1/30/2019 |
Michelle M. DuBois | 10th Plymouth | 1/31/2019 |
Sean Garballey | 23rd Middlesex | 1/26/2019 |
Colleen M. Garry | 36th Middlesex | 1/11/2019 |
Carlos González | 10th Hampden | 2/1/2019 |
James K. Hawkins | 2nd Bristol | 2/1/2019 |
Christopher Hendricks | 11th Bristol | 1/14/2019 |
Louis L. Kafka | 8th Norfolk | 1/25/2019 |
Patrick Joseph Kearney | 4th Plymouth | 1/14/2019 |
Kay Khan | 11th Middlesex | 2/1/2019 |
Joseph W. McGonagle, Jr. | 28th Middlesex | 1/31/2019 |
Christina A. Minicucci | 14th Essex | 1/17/2019 |
Rebecca L. Rausch | Norfolk, Bristol and Middlesex | 1/30/2019 |
John H. Rogers | 12th Norfolk | 1/31/2019 |
José F. Tosado | 9th Hampden | 2/1/2019 |
Steven Ultrino | 33rd Middlesex | 1/25/2019 |
HOUSE DOCKET, NO. 276 FILED ON: 1/9/2019
HOUSE . . . . . . . . . . . . . . . No. 1115
By Mr. Stanley of Waltham, a petition (accompanied by bill, House, No. 1115) of Thomas M. Stanley and others relative to insurance coverage and payment for prescribed treatment for mitochondrial disease. Financial Services. |
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 571 OF 2017-2018.]
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-First General Court
(2019-2020)
_______________
An Act relative to the care and treatment of patients with mitochondrial disease.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
SECTION 1. Chapter 32A of the General Law is hereby amended by inserting after section 17K the following section:-
Section 17L. The commission shall provide to any active or retired employee of the commonwealth or spouse/dependent who is insured under the group insurance commission, coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.
SECTION 2. Chapter 175 of the General Laws is hereby amended by inserting after section 47DD the following section:-
Section 47EE. Any policy, contract, agreement, plan or certificate of insurance issued, delivered or renewed within the commonwealth shall provide coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.
SECTION 3. Chapter 176A of the General Laws is hereby amended by inserting after section 8EE the following section:-
Section 8FF. Any contract between a subscriber and a corporation under an individual or group hospital service plan delivered, issued or renewed within the commonwealth shall provide coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.
SECTION 4. Chapter 176B of the General Laws is hereby amended by inserting after section 4FF the following section:-
Section 4GG. Any subscription certificate under an individual or group medical service agreement delivered, issued or renewed within the commonwealth shall provide coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.
SECTION 5. Chapter 176G of the General Laws is hereby amended by inserting after section 4X the following section:-
Section 4Y. Any individual or group health maintenance contract shall provide coverage for treatment of mitochondrial disease. Said treatment shall include, but not be limited to, the use of vitamin and nutritional supplements, such as CoEnzyme Q10, Vitamin E, Vitamin C, Vitamin B1, Vitamin B2, Vitamin K1 and L-Carnitine.